Posts by Madhur Nayan, MDCM, PhD
-
Review: Active Surveillance for Intermediate-risk Prostate Cancer
Madhur Nayan, MDCM, PhD, Filipe L. F. Carvalho, MD, PhD, and Adam S. Feldman, MD, MPH, recently published a narrative review that discusses variations in the definitions of intermediate-risk prostate cancer and the scant evidence about when it can be managed with active surveillance.
-
Predicted Survival After Radical Prostatectomy Varied by Race With a Trained Machine Classifier
Using a U.S. cancer database, Madhur Nayan, MDCM, PhD, and colleagues trained a machine-learning algorithm to predict survival after radical prostatectomy in race-specific subgroups. Nevertheless, the algorithm overestimated the survival of patients whose race was not listed as white or African American.
-
Using Machine Learning to Predict Prostate Cancer Progression During Active Surveillance
Madhur Nayan, MDCM, PhD, and Adam S. Feldman, MD, MPH, and colleagues created the first machine learning models for predicting prostate cancer progression during active surveillance and found they outperformed traditional logistic regression.
Biography
Madhur Nayan, MDCM, PhD, is a fellow in the Combined Harvard Program in Urologic Oncology at Massachusetts General Hospital.
Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program
Physicians in the Mass General Bladder, Kidney, Penile, Prostate and Testicular Cancer Program specialize in using advanced surgical therapies and minimally invasive procedures to treat male and female genitourinary cancers.
